U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07232238) titled 'TRPM2 Gene Polymorphism, NLRP3 Inflammasome Expression in Vitiligo Patients.' on Nov. 14.
Brief Summary: This study investigates the association between TRPM2 gene polymorphism and NLRP3 inflammasome expression in patients with vitiligo. A case-control design will be conducted among patients attending the Dermatology, Venereology, and Andrology Outpatient Clinic at Aswan University Hospital. The study aims to evaluate TRPM2 genetic variants and their relationship with NLRP3 inflammasome expression, disease onset, and severity in vitiligo patients compared with healthy controls.
Study Start Date: Oct. 20
Study Type: OBSERVATIONAL
...